Clinical Trials in Grafton, New Zealand
Locations / Grafton, New Zealand
Delta Trials records 348 clinical trials conducted in Grafton, New Zealand, making it a notable site of clinical research activity. These trials across 622 distinct therapeutic areas, reflecting the scope and diversity of clinical research in this location. Since 2020, 35 trials in this location were terminated, reflecting shifts in research priorities or feasibility. Delta Trials updates this record as new data becomes available from ClinicalTrials.gov, providing a versioned view of how research activity in Grafton has changed over time.
348
Total Trials
622
Conditions
35
Terminated since 2020
Browse by condition (622 total)
- Chronic hepatitis b 10 trialsAll Chronic hepatitis b trials
- Acute lymphoblastic leukemia 8 trialsAll Acute lymphoblastic leukemia trials
- Hepatitis b, chronic 8 trialsAll Hepatitis b, chronic trials
- Hepatitis c, chronic 7 trialsAll Hepatitis c, chronic trials
- Hepatitis c 7 trialsAll Hepatitis c trials
- Ulcerative colitis 7 trialsAll Ulcerative colitis trials
- Crohn's disease 7 trialsAll Crohn's disease trials
- Acute myeloid leukemia 6 trialsAll Acute myeloid leukemia trials
- Adult rhabdomyosarcoma 5 trialsAll Adult rhabdomyosarcoma trials
- Recurrent neuroblastoma 5 trialsAll Recurrent neuroblastoma trials
- Stage 4 neuroblastoma 5 trialsAll Stage 4 neuroblastoma trials
- Ganglioneuroblastoma 5 trialsAll Ganglioneuroblastoma trials
- Hepatitis c virus infection 5 trialsAll Hepatitis c virus infection trials
- Healthy volunteers 5 trialsAll Healthy volunteers trials
- Stage 4s neuroblastoma 5 trialsAll Stage 4s neuroblastoma trials
- Gout 5 trialsAll Gout trials
- B acute lymphoblastic leukemia 4 trialsAll B acute lymphoblastic leukemia trials
- Stage iii kidney wilms tumor 4 trialsAll Stage iii kidney wilms tumor trials
- Non-small cell lung cancer 4 trialsAll Non-small cell lung cancer trials
- Cystic fibrosis 4 trialsAll Cystic fibrosis trials